TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
640,717
|
504,255
|
406,907 |
Financial expenses |
9,255
|
4,893
|
5,113 |
Earnings before taxes |
126,201
|
139,942
|
107,704 |
Total assets |
381,062
|
378,532
|
282,382 |
Current assets |
338,348
|
331,928
|
225,603 |
Current liabilities |
232,775
|
222,926
|
148,571 |
Equity capital |
148,287
|
152,743
|
131,169 |
- share capital |
6,798
![]() |
6,798
![]() |
6,798 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
38.9%
|
40.4%
|
46.5% |
Turnover per employee | 18,496 | ||
Profit as a percentage of turnover |
19.7%
|
27.8%
|
26.5% |
Return on assets (ROA) |
35.5%
|
38.3%
|
40.0% |
Current ratio |
145.4%
|
148.9%
|
151.8% |
Return on equity (ROE) |
85.1%
|
91.6%
|
82.1% |
Change turnover |
136,462
|
97,348
|
-36,143 |
Change turnover % |
27%
|
24%
|
-8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.